India to Philippines: Oxaliplatin Export Trade Route
India has recorded 151 verified shipments of Oxaliplatin exported to Philippines, representing a combined trade value of $1.2M USD. This corridor is served by 21 active Indian exporters, with an average shipment value of $7.9K USD. The leading Indian exporter is ADMAC LIFESCIENCES, which accounts for 17% of total export value with 18 shipments worth $196.4K USD. On the buying side, VE PHARMA INC is the largest importer in Philippines with $220.3K USD in purchases. The top 3 suppliers — ADMAC LIFESCIENCES, VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD. — together control 42% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Philippines Oxaliplatin corridor is one of India's established pharmaceutical export routes, with 151 shipments documented worth a combined $1.2M USD. The route is dominated by ADMAC LIFESCIENCES, which alone accounts for roughly 17% of all export value, reflecting the consolidated nature of India's oxaliplatin manufacturing sector.
Across 21 active suppliers, the average shipment value stands at $7.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with oxaliplatin's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 11.0%, placing it at rank #7 among India's top oxaliplatin export destinations globally.
On the import side, key buyers of Indian oxaliplatin in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN and 30 others. VE PHARMA INC is the single largest importer with 47 shipments valued at $220.3K USD.
Route Characteristics
- Average transit28 days
- Peak seasonQ1
- Primary modeSea freight
- Top portDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#7
- Annual growth+11.0%
- Demand growth+10.1%
- Regulatory ease71/100
Top 10 Indian Oxaliplatin Exporters to Philippines
Showing top 10 of 21 Indian suppliers exporting Oxaliplatin to Philippines, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ADMAC LIFESCIENCES Avg $10.9K per shipment | 18 | $196.4K | 16.5% |
| 2 | VEXXA LIFESCIENCES PVT. LTD. Avg $5.4K per shipment | 30 | $161.2K | 13.6% |
| 3 | VEXXA LIFESCIENCES PVT. LTD. Avg $4.8K per shipment | 30 | $144.6K | 12.2% |
| 4 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $42.9K per shipment | 3 | $128.7K | 10.8% |
| 5 | NAPROD LIFE SCIENCES PRIVATE LIMITED Avg $51.6K per shipment | 2 | $103.2K | 8.7% |
| 6 | VEXXA LIFESCIENCES PVT LTD Avg $5.3K per shipment | 13 | $69.1K | 5.8% |
| 7 | ADMAC LIFESCIENCES Avg $8.7K per shipment | 6 | $52.3K | 4.4% |
| 8 | INTAS PHARMACEUTICALS LIMITED Avg $10.6K per shipment | 4 | $42.4K | 3.6% |
| 9 | FRESENIUS KABI ONCOLOGY LIMITED Avg $5.0K per shipment | 8 | $39.7K | 3.3% |
| 10 | VENUS REMEDIES LIMITED Avg $7.3K per shipment | 5 | $36.6K | 3.1% |
This table shows the top 10 of 21 Indian companies exporting oxaliplatin to Philippines, ranked by total trade value. The listed exporters are: ADMAC LIFESCIENCES, VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD., NAPROD LIFE SCIENCES PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED , VEXXA LIFESCIENCES PVT LTD, ADMAC LIFESCIENCES , INTAS PHARMACEUTICALS LIMITED , FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED. ADMAC LIFESCIENCES is the dominant supplier with 18 shipments worth $196.4K USD, giving it a 17% market share. The top 3 suppliers together account for 42% of the total trade value on this route.
Showing top 10 of 21 total Indian exporters on the India to Philippines Oxaliplatin export route.
Top 10 Oxaliplatin Importers in Philippines
Showing top 10 of 33 known buyers in Philippines receiving Oxaliplatin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian oxaliplatin in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN, AMBICA INTERNATIONAL CORPORATION, MULTICARE PHARMACEUTICALS PHILIPPIN , among 33 total buyers. The largest importer is VE PHARMA INC, accounting for $220.3K USD across 47 shipments — representing 19% of all oxaliplatin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VE PHARMA INC | 47 | $220.3K | 18.5% |
| 2 | Ve Pharma Inc. | 28 | $142.9K | 12.0% |
| 3 | MULTICARE PHARMACEUTICALS PHILIPPIN | 3 | $128.7K | 10.8% |
| 4 | AMBICA INTERNATIONAL CORPORATION | 8 | $110.4K | 9.3% |
| 5 | MULTICARE PHARMACEUTICALS PHILIPPIN | 2 | $103.2K | 8.7% |
| 6 | PHARMASTAR INTL TRADING CORP. | 4 | $42.9K | 3.6% |
| 7 | ASIA UNITED BANK CORPORATION | 4 | $42.4K | 3.6% |
| 8 | FRESENIUS KABI PHILIPPINES, INC | 8 | $39.7K | 3.3% |
| 9 | PHARMASTAR INTL TRADING CORP | 5 | $39.4K | 3.3% |
| 10 | NELPA LIFESCIENCE INC | 1 | $25.8K | 2.2% |
Showing top 10 of 33 Oxaliplatin importers in Philippines on this route.
Top 10 Oxaliplatin Formulations Imported by Philippines
Showing top 10 of 90 product formulations shipped on the India to Philippines Oxaliplatin route, ranked by trade value
Philippines imports a wide range of oxaliplatin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ZILDOX-50 (OXALIPLATIN FOR INJECTION USP — accounts for $103.2K USD across 2 shipments. There are 90 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZILDOX-50 (OXALIPLATIN FOR INJECTION USP | 2 | $103.2K | 8.7% |
| 2 | Vexplatin 50 (OXALIPLATIN INJECTION BP ( | 20 | $98.1K | 8.3% |
| 3 | Vexplatin 50 Inj (OXALIPLATIN INJECTIONBP (50MG/25ML) BATCH NO-OXIB25A04-A MFGDT-FEB-2025 EXP DT-JAN-2027 | 4 | $52.1K | 4.4% |
| 4 | ZILDOX-50 (OXALIPLATIN FOR INJECTION USP50MG) (3000 VIALS)VLS | 1 | $48.1K | 4.0% |
| 5 | Zildox-50 (Oxaliplatin For Injection USP50mg) (3000 VIALS) | 1 | $47.8K | 4.0% |
| 6 | VEXPLATIN 50 INJ (OXALIPLATIN INJECTION | 6 | $42.4K | 3.6% |
| 7 | APLIXATIN 100 INJ (OXALIPLATIN INJECTION100 MG(100MG/50ML) BT NO OXIL24B14-A MFG DT 12/2024 EXP DT 11-2026 | 1 | $34.3K | 2.9% |
| 8 | ZILDOX 50 OXALIPLATIN FOR INJECTION USP50MG 2057 VIALS | 1 | $32.8K | 2.8% |
| 9 | INJ.OXANISH 50(OXALIPLATIN INJECTION BP | 3 | $29.6K | 2.5% |
| 10 | PHARMA DRUG&MED:Meslatin 100-Oxaliplatin | 2 | $29.4K | 2.5% |
Showing top 10 of 90 Oxaliplatin formulations imported by Philippines on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 56 shipments. Transit time averages 28 days by sea.
Market Dynamics
India's oxaliplatin exports to Philippines are driven primarily by a handful of large-scale manufacturers. ADMAC LIFESCIENCES with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Philippines benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ADMAC LIFESCIENCES, VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD. — together account for 42% of total trade value on this route. The average shipment value of $7.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as vexplatin 50 (oxaliplatin injection bp ( and vexplatin 50 inj (oxaliplatin injectionbp (50mg/25ml) batch no-oxib25a04-a mfgdt-feb-2025 exp dt-jan-2027, suggesting that buyers in Philippines tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, VE PHARMA INC is the largest importer with 47 shipments worth $220.3K USD — representing 19% of all oxaliplatin imports from India on this route. A total of 33 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.2M
- Avg. Shipment
- $7.9K
- Suppliers
- 21
- Buyers
- 33
- Transit (Sea)
- ~28 days
- Annual Growth
- +11.0%
Related Analysis
Other Oxaliplatin Routes
Unlock the Full India to Philippines Oxaliplatin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 151 shipments on this route.
Frequently Asked Questions — India to Philippines Oxaliplatin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Oxaliplatin to Philippines?
The leading Indian exporters of Oxaliplatin to Philippines are ADMAC LIFESCIENCES, VEXXA LIFESCIENCES PVT. LTD. , VEXXA LIFESCIENCES PVT. LTD.. ADMAC LIFESCIENCES holds the largest market share at approximately 17% of total trade value on this route.
Q What is the total value of Oxaliplatin exports from India to Philippines?
India exports Oxaliplatin to Philippines worth approximately $1.2M USD across 151 recorded shipments. The average value per shipment is $7.9K USD.
Q Which ports does India use to ship Oxaliplatin to Philippines?
The most active port of origin is DELHI AIR CARGO ACC (INDEL4) with 56 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to Philippines for Oxaliplatin?
The average transit time for Oxaliplatin shipments from India to Philippines is approximately 28 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Philippines Oxaliplatin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.0% with demand growth tracking at 10.1%. The route is ranked #7 among India's top Oxaliplatin export destinations globally.
Q How many suppliers are active on the India to Philippines Oxaliplatin route?
There are currently 21 active Indian suppliers exporting Oxaliplatin to Philippines. The market is moderately concentrated with ADMAC LIFESCIENCES accounting for 17% of total shipment value.
Q Who are the main importers of Oxaliplatin from India in Philippines?
The leading importers of Indian Oxaliplatin in Philippines include VE PHARMA INC, Ve Pharma Inc. , MULTICARE PHARMACEUTICALS PHILIPPIN, AMBICA INTERNATIONAL CORPORATION, MULTICARE PHARMACEUTICALS PHILIPPIN . VE PHARMA INC is the largest buyer with 47 shipments worth $220.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Philippines export trade corridor identified from Indian Customs (DGFT) records for Oxaliplatin.
- 2.Supplier/Buyer Matching: 21 Indian exporters and 33 importers in Philippines matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 151 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
151 Verified Shipments
21 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists